Axon Enterprise 10-Q 2024-09-30
Filed 2024-11-08. 8 sections, 385K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2024
or
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from __________to __________
Commission File Number: 001-16391
| Axon Enterprise, Inc. | ||||||||
| (Exact name of registrant as specified in its charter) |
| Delaware | 86-0741227 | ||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| 17800 North 85th Street | |||||
| Scottsdale, Arizona | 85255 | ||||
| (Address of principal executive offices) | (Zip Code) |
(480) 991-0797
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, $0.00001 Par Value | AXON | The NASDAQ Global Select Market |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | o | |||||||||||
| Non-accelerated Filer | o | Smaller reporting company | o | |||||||||||
| Emerging growth company | o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of the registrant’s common stock outstanding as of November 1, 2024 was 76,254,776.
AXON ENTERPRISE, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements regarding our expectations, beliefs, intentions and strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. From time to time, we also provide forward-looking statements in other materials we release to the public as well as verbal forward-looking statements. These forward-looking statements include, without limitation, statements regarding: proposed products and services and related development efforts and activities; expectations about the market for our current and future products and services; the impact of pending litigation; strategies and trends relating to subscription plan programs and revenues; statements related to recently completed acquisitions; our anticipation that contracts with governmental customers will be fulfilled; strategies and trends, including the amounts and benefits of, research and development (“R&D”) investments; the sufficiency of our liquidity and financial resources; expectations about customer behavior; the impact on our investment portfolio of changes in interest rates; our potential use of foreign currency forward and option contracts; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; statements of management’s strategies, goals and objectives and other similar expressions; as well as the ultimate resolution of financial statement items requiring critical accounting estimates, including those set forth in our Annual Report on Form 10-K for the year ended December 31, 2023. Such statements give our current expectations or forecasts of future events; they do not relate strictly to historical or current facts. Words such as “may,” “will,” “should,” “could,” “would,” “predict,” “potential,” “continue,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” and similar expressions, as well as statements in future tense, identify forward-looking statements. However, not all forward-looking statements contain these identifying words.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. The following important factors could cause actual results to differ materially from those in the forward-looking statements: our exposure to cancellations of government contracts due to appropriation clauses, exercise of a cancellation clause, or non-exercise of contractually optional periods; the ability of law enforcement agencies to obtain funding, including based on tax revenues; our ability to design, introduce and sell new products, services or features; our ability to defend against litigation and protect our intellectual property, and the resulting costs of this activity; our ability to win bids through the open bidding process for governmental agencies; our ability to manage our supply chain and avoid production delays, shortages and impacts to expected gross margins; the impacts of inflation, macroeconomic conditions and global events; the impact of catastrophic events or public health emergencies; the impact of stock-based compensation expense, impairment expense, and income tax expense on our financial results; customer purchase behavior, including adoption of our software as a service delivery model; negative media publicity or sentiment regarding our products; the impact of various factors on projected gross margins; defects in, or misuse of, our products; changes in the costs of product components and labor; loss of customer data, a breach of security, or an extended outage, including by our third party cloud-based storage providers; exposure to international operational risks; delayed cash collections and possible credit losses due to our subscription model; changes in government regulations in the United States and in foreign markets, especially related to the classification of our products by the United States Bureau of Alcohol, Tobacco, Firearms and Explosives; our ability to integrate acquired businesses; the impact of declines in the fair values or impairment of our investments, including our strategic investments; our ability to attract and retain key personnel; litigation or inquiries and related time and costs; and counter-party risks relating to cash balances held in excess of federally insured limits. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements. This Quarterly Report on Form 10-Q lists various important factors that could cause actual results to differ materially from expected and historical results. These factors are intended as cautionary statements for investors within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Readers can find them under the heading “Risk Factors” in this Quarterly Report on Form 10-Q, and investors should refer to them. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-Q, 8-K and 10-K reports to the Securities and Exchange Commission (“SEC”). Our filings with the SEC may be accessed at the SEC’s web site at www.sec.gov.
ii
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
AXON ENTERPRISE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| September 30, 2024 | December 31, 2023 | ||||||||||
| (Unaudited) | |||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 695,144 | $ | 598,545 | |||||||
| Marketable securities | 151,560 | 77,940 | |||||||||
| Short-term investments | 311,570 | 644,054 | |||||||||
| Accounts and notes receivable, net of allowance of $3,292 and $2,392 as of September 30, 2024 and December 31, 2023, respectively | 512,662 | 412,961 | |||||||||
| Contract assets, net | 372,923 | 287,232 | |||||||||
| Inventory | 272,295 | 269,855 | |||||||||
| Prepaid expenses and other current assets | 117,592 | 103,055 | |||||||||
| Total current assets | 2,433,746 | 2,393,642 | |||||||||
| Property and equipment, net | 235,881 | 200,533 | |||||||||
| Deferred tax assets, net | 244,317 | 227,784 | |||||||||
| Intangible assets, net | 81,748 | 19,539 | |||||||||
| Goodwill | 308,472 | 57,945 | |||||||||
| Long-term notes receivable, net | 2,898 | 2,588 | |||||||||
| Long-term contract assets, net | 119,973 | 84,382 | |||||||||
| Strategic investments | 387,905 | 231,730 | |||||||||
| Other long-term assets | 190,718 | 191,031 | |||||||||
| Total assets | $ | 4,005,658 | $ | 3,409,174 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 75,590 | $ | 65,852 | |||||||
| Accrued liabilities | 209,691 | 193,550 | |||||||||
| Current portion of deferred revenue | 505,008 | 470,415 | |||||||||
| Customer deposits | 22,234 | 21,935 | |||||||||
| Other current liabilities | 10,704 | 9,787 | |||||||||
| Total current liabilities | 823,227 | 761,539 | |||||||||
| Deferred revenue, net of current portion | 305,414 | 270,901 | |||||||||
| Liability for unrecognized tax benefits | 20,342 | 18,049 | |||||||||
| Long-term deferred compensation | 15,605 | 11,342 | |||||||||
| Long-term lease liabilities | 41,223 | 33,550 | |||||||||
| Convertible notes, net | 679,483 | 677,113 | |||||||||
| Other long-term liabilities | 20,528 | 20,915 | |||||||||
| Total liabilities | 1,905,822 | 1,793,409 | |||||||||
| Commitments and contingencies (Note 14) | |||||||||||
| Stockholders’ equity: | |||||||||||
| Preferred stock, $0.00001 par value; 25,000,000 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | — | — | |||||||||
| Common stock, $0.00001 par value; 200,000,000 shares authorized; 76,084,179 and 75,301,424 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively | 1 | 1 | |||||||||
| Additional paid-in capital | 1,588,072 | 1,347,410 | |||||||||
| Treasury stock at cost, 20,220,227 shares as of September 30, 2024 and December 31, 2023 | (155,947) | (155,947) | |||||||||
| Retained earnings | 676,830 | 434,980 | |||||||||
| Accumulated other comprehensive loss | (9,120) | (10,679) | |||||||||
| Total stockholders’ equity | 2,099,836 | 1,615,765 | |||||||||
| Total liabilities and stockholders’ equity | $ | 4,005,658 | $ | 3,409,174 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
AXON ENTERPRISE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(in thousands, except per share data)
(unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Net sales from products | $ | 327,900 | $ | 255,055 | $ | 891,087 | $ | 707,563 | |||||||||||||||
| Net sales from services | 216,374 | 158,223 | 616,294 | 422,760 | |||||||||||||||||||
| Net sales | 544,274 | 413,278 | 1,507,381 | 1,130,323 | |||||||||||||||||||
| Cost of product sales | 156,167 | 114,613 | 450,954 | 323,808 | |||||||||||||||||||
| Cost of service sales | 57,360 | 42,009 | 160,896 | 115,054 | |||||||||||||||||||
| Cost of sales | 213,527 | 156,622 | 611,850 | 438,862 | |||||||||||||||||||
| Gross margin | 330,747 | 256,656 | 895,531 | 691,461 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Sales, general and administrative | 192,189 | 122,357 | 514,228 | 357,611 | |||||||||||||||||||
| Research and development | 114,477 | 76,880 | 307,008 | 219,747 | |||||||||||||||||||
| Total operating expenses | 306,666 | 199,237 | 821,236 | 577,358 | |||||||||||||||||||
| Income from operations | 24,081 | 57,419 | 74,295 | 114,103 | |||||||||||||||||||
| Interest income, net | 10,978 | 10,458 | 31,134 | 29,787 | |||||||||||||||||||
| Other income (loss), net | 44,510 | 3,852 | 191,510 | (42,569) | |||||||||||||||||||
| Income before provision for income taxes | 79,569 | 71,729 | 296,939 | 101,321 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 12,544 | 10,420 | 55,089 | (17,401) | |||||||||||||||||||
| Net income | $ | 67,025 | $ | 61,309 | $ | 241,850 | $ | 118,722 | |||||||||||||||
| Net income per common and common equivalent shares: | |||||||||||||||||||||||
| Basic | $ | 0.89 | $ | 0.82 | $ | 3.20 | $ | 1.61 | |||||||||||||||
| Diluted | $ | 0.86 | $ | 0.81 | $ | 3.12 | $ | 1.58 | |||||||||||||||
| Weighted average number of common and common equivalent shares outstanding: | |||||||||||||||||||||||
| Basic | 75,697 | 74,826 | 75,543 | 73,904 | |||||||||||||||||||
| Diluted | 78,080 | 75,952 | 77,614 | 75,212 | |||||||||||||||||||
| CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||||||||||||||||||||||
| Net income | $ | 67,025 | $ | 61,309 | $ | 241,850 | $ | 118,722 | |||||||||||||||
| Foreign currency translation adjustments | 4,640 | (6,799) | 1,112 | (5,680) | |||||||||||||||||||
| Unreali |
Showing the first 8K of 163K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition as of September 30, 2024, and results of operations for the three and nine months ended September 30, 2024 and 2023, should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 27, 2024. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Part II, Item 1A. Risk Factors.” See also “Special Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.
Overview
Axon is a technology leader in global public safety. Our moonshot goal is to cut gun-related deaths between police and the public by 50% before 2033. Axon is building the public safety operating system of the future by integrating a suite of hardware devices and cloud software solutions that lead modern policing. Axon’s technology suite includes TASER energy devices, body-worn cameras, in-car cameras, cloud-hosted digital evidence management solutions, productivity software and real-time operations capabilities. Axon’s growing global customer base includes first responders across international, federal, state, and local law enforcement, fire, corrections, and emergency medical services, as well as the justice sector, commercial enterprises, and consumers.
Our revenues for the three months ended September 30, 2024 were $544.3 million, an increase of $131.0 million, or 31.7%, from the comparable period in the prior year. We had income from operations of $24.1 million, compared to $57.4 million for the same period in the prior year. Gross margin dollars increased $74.1 million but decreased as a percentage of revenue to 60.8% from 62.1% compared to the three months ended September 30, 2023. The decrease was primarily driven by higher stock-based compensation expense and related payroll taxes, as well as amortization of acquired intangibles. Excluding the impacts of stock-based compensation expense and intangibles amortization in the cost of goods sold, gross margin increased from 62.7% to 63.2% year over year due to an increased mix of high-margin Axon Cloud & Services revenue. Operating expenses increased by $107.4 million, reflecting increased headcount and an increase in stock-based compensation expense. Net income of $67.0 million included a noncash unrealized gain of $44.0 million in our marketable securities. Net income of $61.3 million for the comparable period in the prior year included a noncash unrealized gain of $4.1 million on our investment in marketable securities.
Our revenues for the nine months ended September 30, 2024 were $1.5 billion, an increase of $377.1 million, or 33.4%, from the comparable period in the prior year. We had income from operations of $74.3 million, compared to $114.1 million for the same period in the prior year. Gross margin dollars increased $204.1 million but decreased as a percentage of revenue to 59.4% from 61.2% compared to the nine months ended September 30, 2023. The decrease was primarily driven by higher stock-based compensation expense and related payroll taxes, as well as amortization of acquired intangibles. Excluding the impacts of stock-based compensation expense and intangibles amortization in the cost of goods sold, the gross margin increased to 63.2% for the nine months ended September 30, 2024, compared to 61.8% for the same period in the prior year, primarily due to an increased mix of high-margin Axon Cloud & Services revenue and investments in TASER automation and cost-reduction initiatives. Operating expenses increased $243.9 million, reflecting an increase in salaries, benefits, and stock-based compensation expenses, as well as an increase in professional and consulting expenses related to transaction costs. For the nine months ended September 30, 2024, we recorded net income of $241.9 million, which included realized and unrealized gains of $192.2 million related to our acquisition of Fusus, strategic equity investment and marketable securities. Net income of $118.7 million for the comparable period in the prior year reflected a noncash unrealized gain of $29.6 million on our investment in marketable securities and a noncash unrealized impairment loss of $71.9 million, net, related to a strategic investment and related warrants.
Certain prior period amounts previously reported on our consolidated financial statements have been revised to correct for immaterial errors, as described in Note 1 and Note 19 to our condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q.
Results of Operations
Three Months Ended September 30, 2024 Compared to the Three Months Ended September 30, 2023
The following table presents data from our condensed consolidated statements of operations as well as the percentage relationship to total net sales of items included in our statements of operations (dollars in thousands):
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||
| Net sales from products | $ | 327,900 | 60.2 | % | $ | 255,055 | 61.7 | % | |||||||||||||||
| Net sales from services | 216,374 | 39.8 | 158,223 | 38.3 | |||||||||||||||||||
| Net sales | 544,274 | 100.0 | 413,278 | 100.0 | |||||||||||||||||||
| Cost of product sales | 156,167 | 28.7 | 114,613 | 27.7 | |||||||||||||||||||
| Cost of service sales | 57,360 | 10.5 | 42,009 | 10.2 | |||||||||||||||||||
| Cost of sales | 213,527 | 39.2 | 156,622 | 37.9 | |||||||||||||||||||
| Gross margin | 330,747 | 60.8 | 256,656 | 62.1 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Sales, general and administrative | 192,189 | 35.3 | 122,357 | 29.6 | |||||||||||||||||||
| Research and development | 114,477 | 21.0 | 76,880 | 18.6 | |||||||||||||||||||
| Total operating expenses | 306,666 | 56.3 | 199,237 | 48.2 | |||||||||||||||||||
| Income from operations | 24,081 | 4.5 | 57,419 | 13.9 | |||||||||||||||||||
| Interest income, net | 10,978 | 2.0 | 10,458 | 2.5 | |||||||||||||||||||
| Other income (loss), net | 44,510 | 8.1 | 3,852 | 0.9 | |||||||||||||||||||
| Income (loss) before provision for income taxes | 79,569 | 14.6 | 71,729 | 17.3 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 12,544 | 2.3 | 10,420 | 2.5 | |||||||||||||||||||
| Net income | $ | 67,025 | 12.3 | % | $ | 61,309 | 14.8 | % |
The following table presents our revenues disaggregated by geography (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Showing the first 8K of 65K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
We typically invest in a limited number of financial instruments, consisting principally of investments in money market accounts, certificates of deposit, corporate and municipal bonds with a typical long-term debt rating of “A” or better by any nationally recognized statistical rating organization, denominated in U.S. dollars. All of our cash equivalents and investments are treated as “available-for-sale”. We report available-for-sale investments at fair value as of each balance sheet date and record any unrealized gains or losses within accumulated other comprehensive income (loss) as a component of stockholders’ equity. The cost of securities sold is determined on a specific identification basis, and realized gains and losses are included in interest and other income (expense), net within the condensed consolidated statements of operations. When the fair value is below the amortized cost of a marketable security, an estimate of expected credit losses is made. The credit-related impairment amount is recognized in the condensed consolidated statements of operations. Credit losses are recognized through the use of an allowance for credit losses account in the condensed consolidated balance sheet and subsequent improvements in expected credit losses are recognized as a reversal of an amount in the allowance account. If we have the intent to sell the security or it is more likely than not that we will be required to sell the security prior to recovery of its amortized cost basis, then the allowance for the credit loss is written-off and the excess of the amortized cost basis of the asset over its fair value is recorded in the condensed consolidated statements of operations. Based on investment positions as of September 30, 2024, a hypothetical 100 basis point increase in interest rates across all maturities would result in a $0.4 million decline in the fair market value of the portfolio. Such losses would only be realized if we sold the investments prior to maturity.
Additionally, we have access to a $200.0 million line of credit borrowing facility which bears interest at SOFR plus 1.25 to 1.75% per year determined in accordance with a pricing grid based on our net leverage ratio and consolidated interest coverage ratio. Under the terms of the line of credit, available borrowings are reduced by outstanding letters of credit, which totaled $8.2 million at September 30, 2024. At September 30, 2024, there was no amount outstanding under the line of credit, and the available borrowing under the line of credit was $191.8 million. We have not borrowed any funds under the line of credit since its inception; however, should we need to do so in the future, such borrowings could be subject to adverse or favorable changes in the underlying interest rate.
Exchange Rate Risk
Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, in each case compared to the U.S. dollar, related to transactions by our foreign subsidiaries. The majority of our sales to international customers are transacted in foreign currencies and therefore are subject to exchange rate fluctuations on these transactions. The cost of our products to our customers increases when the U.S. dollar strengthens against their local currency, and we may have more sales and expenses denominated in foreign currencies in future years, which could increase our foreign exchange rate risk. Additionally, intercompany sales to our non-U.S. dollar functional currency international subsidiaries are transacted in U.S. dollars, which could increase our foreign exchange rate risk caused by foreign currency transaction gains and losses.
To date, we have not engaged in any currency hedging activities. However, we may enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks associated with certain existing assets and liabilities, certain firmly committed transactions, forecasted future cash flows and net investments in foreign subsidiaries. However, we may choose not to hedge certain foreign exchange exposures for a variety of reasons, including, but not limited to, the prohibitive economic cost of hedging particular exposures. As such, fluctuations in currency exchange rates could harm our business in the future.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer are responsible for the evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Our disclosure controls and procedures are designed to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2024.
There was no change in our internal control over financial reporting during the quarter ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The discussion in Note 14 to our condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.
Item 1A. Risk Factors
Risk Factor Summary
The following is only a summary of the principal risks that may materially adversely affect our business, financial condition, results of operations and cash flows. The following should be read in conjunction with the more complete discussion of the risks we face, which are set forth more fully below.
Strategic Risks
-
If law enforcement agencies do not continue to purchase and use our products and services, our growth prospects, operating results and financial condition will be materially adversely affected.
-
If our CEDs do not continue to be widely accepted, our growth prospects, operating results and financial condition will be diminished.
-
If we are unable to design, introduce, sell and deploy new products or new product features successfully, our business and financial results could be adversely affected.
-
We face risks associated with rapid technological change and new competing products.
-
Our future success is dependent on our ability to expand sales through direct sales and distributors and our inability to increase direct sales or recruit new distributors would negatively affect our sales.
-
Negative publicity could adversely impact sales, which could cause our revenues or operating results to decline.
-
Acquisitions of, or investments in, other products, technologies or businesses could disrupt our business, dilute shareholder value, and adversely affect our operating results.
-
Our failure to retain executive officers, including Patrick W. Smith, could adversely impact our business.
Operational Risks
-
Unavailability of materials or higher costs could adversely affect our financial results.
-
Material adverse developments in domestic and global economic conditions, or the occurrence of other sufficiently disruptive world events, could materially adversely affect our revenue and results of operations.
-
To the extent demand for our products increases, our future success will be dependent upon our ability to manage our growth and to increase manufacturing production capacity.
-
Delays in product development schedules could adversely affect our revenues and cash flows.
-
We expend significant resources in anticipation of a sale and may receive no revenue in return.
-
Changes in civil forfeiture laws may affect our customers’ ability to purchase our products.
-
If our security measures or those of our third-party providers, including cloud storage providers, are breached and unauthorized access is obtained to customers’ data or our data, our network, data centers and service may be perceived as not being secure, customers may curtail or stop using our products and services, and we may incur significant legal and financial exposure and liabilities.
-
Catastrophic events could materially adversely affect our business, results of operations and/or financial condition.
-
Uncertainty in the development, deployment and use of artificial intelligence (“AI”) in our products and services, as well as our business more broadly, could adversely affect our business and reputation.
-
Defects or disruptions in our services could impact demand for our services and subject us to substantial liability.
-
Defects in our products could reduce demand for our products or result in product recalls and result in a loss of sales, delay in market acceptance and damage to our reputation.
-
Our international operations expose us to additional risks that could harm our business, operating results and financial condition.
-
We depend on our ability to attract and retain our key management, sales and technical personnel.
-
If we fail to comply with federal, state or local regulations applicable to TASER 10 CEDs, we may be subject to governmental actions or litigation that could materially harm our business.
-
Failure to maintain effective internal control over financial reporting, material weaknesses, or significant deficiencies may adversely affect our ability to accurately and timely report our financial condition and results of operations, which may cause investor confidence to diminish and the value of our common stock may decline.
-
Our revision of previously issued consolidated financial statements may adversely affect investor confidence and could result in regulatory and litigation risks.
Financial Risks
-
An increasing percentage of our revenue is derived from subscription billing arrangements that may result in delayed cash collections and may increase customer credit risk on receivables and contract assets.
-
Our gross margin is dependent on a number of factors, including our product mix, cost structure and acquisitions we may make, any of which could cause our gross margin to decline.
-
Revenue for our Software-as-a-Service (“SaaS”) products is recognized over the terms of the contracts, which may be several years, and, as such, trends in new business may not be immediately reflected in our operating results.
-
Most of our end-user customers are subject to budgetary and political constraints that may delay or prevent sales.
-
The open bidding process creates uncertainty in predicting future contract awards.
-
We maintain most of our cash balances, some of which are not insured, at two depository institutions.
-
Stock transactions may have a material, unpredictable impact on our results of operations and may result in dilution to existing shareholders.
-
Our financial performance is subject to risks associated with changes in the value of the U.S. dollar versus local currencies.
-
Unanticipated changes in our effective tax rate and additional tax liabilities may impact our results of operations and financial condition.
-
Our revenues and operating results may fluctuate unexpectedly, which may cause our common stock price to decline.
-
Our profitability could suffer from declines in fair value or impairment of our investments, including our strategic investments, and could fluctuate if the fair values of our investments increase.
Legal and Compliance Risks
-
We may face personal injury, wrongful death, product liability and other liability claims that harm our reputation and adversely affect our sales and financial condition.
-
Other litigation, government inquiries and regulatory actions may result in significant costs and judgments and divert management attention from our business.
-
We have in the past and may in the future be subject to intellectual property infringement and other claims, which could incur substantial litigation costs, result in significant damages awards, inhibit our use of certain technologies, and divert management attention from our business.
-
If we are unable to protect our intellectual property, the value of our brands and products may decrease and we may lose our competitive market advantage.
-
We may be unable to enforce patent rights internationally, which may limit our ability to prevent our product features from being used by competitors in some foreign jurisdictions.
-
The use of open-source software in our products, services and technologies may expose us to additional risks and harm our intellectual property rights.
-
A variety of new and existing laws and/or interpretations could materially adversely affect our business.
-
We are subject to evolving corporate governance and public disclosure regulations and expectations that could expose us to numerous risks.
-
Our amended and restated bylaws include exclusive forum provisions that could increase costs to bring a claim, discourage claims or limit the ability of our shareholders to bring a claim in a judicial forum viewed by shareholders as more favorable for disputes.
Risks Related to our Convertible Notes
-
Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow to pay our substantial debt.
-
The conditional conversion feature of the Notes, if triggered, may adversely affect our operating results.
-
Conversion of the Notes may dilute
Showing the first 8K of 131K characters. Open the full section
Item 5. Other Information
The table below describes the contracts, instructions or written plans for the purchase or sale of securities adopted by our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) during the three months ended September 30, 2024, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Name and Title | Adoption Date | Expiration Date | Aggregate Number of Securities to be Sold | ||||||||||||||
| Brittany Bagley, Chief Operating Officer and Chief Financial Officer | August 16, 2024 | December 31, 2025 | 6,325 | ||||||||||||||
| Caitlin Kalinowski, Director | August 20, 2024 | December 31, 2025 | 450 |
In addition, certain of our officers or directors have made, and may from time to time make, elections to have shares withheld or sold to cover withholding taxes or pay the exercise price of options, which may be designed to satisfy the affirmative defense conditions of Rule 10b5-1 under the Exchange Act or may constitute non-Rule 10b5-1 trading arrangements (as defined in Item 408(c) of Regulation S-K).
No other Rule 10b5-1 trading arrangements or “non-Rule 10b5-1 trading arrangements” (as defined by S-K Item 408(c)) were entered into, modified, or terminated by our directors or officers during such period.
Item 6. Exhibits
| 3.1 | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q, filed August 9, 2022) | ||||
| 3.2 | Bylaws, as amended and restated (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K, filed December 21, 2023) | ||||
| 31.1* | Principal Executive Officer Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) | ||||
| 31.2* | Principal Financial Officer Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) | ||||
| 32** | Principal Executive Officer and Principal Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104* | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL |
+Management contract or compensatory plan or arrangement
*Filed herewith
**Furnished herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AXON ENTERPRISE, INC. | |||||||||||
| Date: | November 7, 2024 | ||||||||||
| By: | /s/ PATRICK W. SMITH | ||||||||||
| Chief Executive Officer | |||||||||||
| (Principal Executive Officer) | |||||||||||
| Date: | November 7, 2024 | By: | /s/ BRITTANY BAGLEY | ||||||||
| Chief Operating Officer and Chief Financial Officer | |||||||||||
| (Principal Financial and | |||||||||||
| Accounting Officer) |